[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

AR037551A1 - Proceso para la preparacion de imipenem monohidratado cristalino y compuesto - Google Patents

Proceso para la preparacion de imipenem monohidratado cristalino y compuesto

Info

Publication number
AR037551A1
AR037551A1 ARP020104429A ARP020104429A AR037551A1 AR 037551 A1 AR037551 A1 AR 037551A1 AR P020104429 A ARP020104429 A AR P020104429A AR P020104429 A ARP020104429 A AR P020104429A AR 037551 A1 AR037551 A1 AR 037551A1
Authority
AR
Argentina
Prior art keywords
imipenem
preparation
crystalline
monohydrate
monohidratado
Prior art date
Application number
ARP020104429A
Other languages
English (en)
Inventor
Bishwa Prakash Rai
Neera Tewari
Velayudhan Nair Gopa Kumar
Original Assignee
Ranbaxy Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Lab Ltd filed Critical Ranbaxy Lab Ltd
Publication of AR037551A1 publication Critical patent/AR037551A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Un proceso rentable y ventajoso para uso industrial para la preparación de imipenem monohidratado cristalino a partir de imipenem crudo con impurezas que incluyen impurezas poliméricas y coloreadas, y el compuesto preparado para aplicación en antibióticos tipo B-lactama, que posee el sistema de anillo carbapenem, frente a especies aeróbicas y anaerobias gram-positivas y gram-negativas. El imipenem monohidratado cristalino y puro presenta la fórmula(1): l proceso para su preparación comprende: (a) disolver imipenem crudo en agua para obtener una solución; (b) someter la solución resultante a un tratamiento con carbón activado; y(c) anadir un solvente orgánico para hacer que el imipenem monohidratado precipite como producto cristalino, imipenem monohidratado es el derivado N-formimidoílo de tienamacina.
ARP020104429A 2001-11-16 2002-11-19 Proceso para la preparacion de imipenem monohidratado cristalino y compuesto AR037551A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN1152DE2001 2001-11-16

Publications (1)

Publication Number Publication Date
AR037551A1 true AR037551A1 (es) 2004-11-17

Family

ID=11097136

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP020104429A AR037551A1 (es) 2001-11-16 2002-11-19 Proceso para la preparacion de imipenem monohidratado cristalino y compuesto

Country Status (15)

Country Link
US (1) US7332600B2 (es)
EP (1) EP1448563A1 (es)
JP (1) JP2005509037A (es)
KR (1) KR20050044506A (es)
CN (1) CN1608066A (es)
AR (1) AR037551A1 (es)
BR (1) BR0214209A (es)
CA (1) CA2467427A1 (es)
EA (1) EA200400682A1 (es)
HR (1) HRP20040552A2 (es)
HU (1) HUP0402112A2 (es)
MX (1) MXPA04004604A (es)
PL (1) PL368984A1 (es)
WO (1) WO2003042215A1 (es)
ZA (1) ZA200403961B (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
OA12608A (en) * 2001-05-18 2006-06-08 Ranbaxy Lab Ltd Process for the isolation of crystalline imiponem.
JP2005023081A (ja) * 2003-06-11 2005-01-27 Api Corporation アルブチン結晶及びその製造方法
US8886272B2 (en) 2004-07-13 2014-11-11 Dexcom, Inc. Analyte sensor
WO2007102842A2 (en) 2006-03-09 2007-09-13 Dexcom, Inc. Systems and methods for processing analyte sensor data
EP4218548A1 (en) 2006-03-09 2023-08-02 Dexcom, Inc. Systems and methods for processing analyte sensor data
EP2121604A2 (en) * 2006-12-15 2009-11-25 Schering Corporation Bisulfite purification of an alpha-keto amide
US8621008B2 (en) 2007-04-26 2013-12-31 Mcafee, Inc. System, method and computer program product for performing an action based on an aspect of an electronic mail message thread
US8199965B1 (en) 2007-08-17 2012-06-12 Mcafee, Inc. System, method, and computer program product for preventing image-related data loss
US20130276061A1 (en) 2007-09-05 2013-10-17 Gopi Krishna Chebiyyam System, method, and computer program product for preventing access to data with respect to a data access attempt associated with a remote data sharing session
EP2209787A4 (en) 2007-10-08 2011-08-03 Orchid Chemicals & Pharm Ltd METHOD FOR PRODUCING A CARBAPENEM ANTIBIOTICS
US8893285B2 (en) 2008-03-14 2014-11-18 Mcafee, Inc. Securing data using integrated host-based data loss agent with encryption detection
US9077684B1 (en) 2008-08-06 2015-07-07 Mcafee, Inc. System, method, and computer program product for determining whether an electronic mail message is compliant with an etiquette policy
CN101891744B (zh) * 2010-07-20 2012-06-13 深圳市海滨制药有限公司 亚胺培南一水合物结晶的制备方法
CN101891745B (zh) * 2010-07-20 2012-06-13 深圳市海滨制药有限公司 亚胺培南一水合物晶体的制备方法
WO2012081033A2 (en) * 2010-12-06 2012-06-21 Sequent Scientific Limited A process for preparation of imipenem
CN103524508B (zh) * 2013-09-02 2016-03-30 上海龙翔生物医药开发有限公司 一种亚胺培南一水合物的结晶方法
CN113135916A (zh) * 2020-01-20 2021-07-20 鲁南制药集团股份有限公司 一种亚胺培南制备工艺的除钯方法
CN111747959B (zh) * 2020-05-15 2022-02-11 深圳市海滨制药有限公司 一种亚胺培南原料药的制备方法
CN114671877B (zh) * 2022-02-18 2023-05-16 珠海联邦制药股份有限公司 亚胺培南的精制方法

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE268240C (es)
JPS606957B2 (ja) * 1973-04-10 1985-02-21 ブリストル マイヤ−ズ カンパニ− 抗生物質誘導体の製造方法
US4194047A (en) 1975-11-21 1980-03-18 Merck & Co., Inc. Substituted N-methylene derivatives of thienamycin
US4260543A (en) * 1978-07-03 1981-04-07 Merck & Co., Inc. Crystalline N-formimidoyl thienamycin
DK153486C (da) * 1978-07-03 1988-11-28 Merck & Co Inc Analogifremgangsmaade til fremstilling af krystallinsk n-formimidoyl-thienamycin-monohydrat
US4292436A (en) 1980-06-25 1981-09-29 Merck & Co., Inc. Process for the preparation of N-protected N-formimidoyl 2-aminoethanethiol
US5061730A (en) * 1987-01-26 1991-10-29 Fujisawa Pharmaceutical Co., Ltd. Carboxylic acid derivatives
DD268240A1 (de) * 1987-12-05 1989-05-24 Univ Schiller Jena Verfahren zur erzeugung von fuer die applikation in optiken aus polymeren werkstoffen geeigneten hochreinen 2-hydroxy-4-alkoxybenzophenonen
US5321020A (en) * 1989-03-28 1994-06-14 Pfizer Inc. Antibacterial 2-carbapenem derivatives
CA2023144A1 (en) * 1989-08-21 1991-02-22 Frank P. Dininno 2-(quinoliniumalkyl and isoquinoliniumalkyl)-phenyl carbapenem antibacterial agents
JPH03256262A (ja) 1990-03-07 1991-11-14 Nec Corp 磁気ディスク装置
US5240920A (en) * 1990-10-11 1993-08-31 Merck & Co., Inc. 2-(substituted-dibenzofuranyl and dibenzothienyl) carbapenem antibacterial agents
JPH06256262A (ja) * 1993-03-08 1994-09-13 Sekiyu Sangyo Kasseika Center ２，６−ナフタレンジカルボン酸ジメチルエステルの精製法
US5621084A (en) * 1994-04-05 1997-04-15 Pfizer Inc. Process for removal of allyl group or allyloxycarbonyl group
CZ288645B6 (cs) * 1995-09-08 2001-08-15 Bracco International B. V. Způsob krystalizace Iopamidolu
CN1216898C (zh) * 1996-03-14 2005-08-31 诺沃奇梅兹有限公司 利用固体吸附材料以提高的产率结晶蛋白质的方法
CN1109688C (zh) * 1999-01-12 2003-05-28 中国药品生物制品检定所 他唑巴坦半水合物的制备与应用
DE60014047T2 (de) 1999-03-22 2006-02-23 Purac Biochem B.V. Verfahren zur reinigung von milchsäure auf industrieller basis
GB9925215D0 (en) * 1999-10-26 1999-12-22 Cerestar Holding Bv Process for the manufacture of citric acid
US20030153191A1 (en) * 2000-03-31 2003-08-14 Izumi Saitoh Novel crystal form of pyrrolidylthiocarbapenem derivative
IN191798B (es) 2000-11-03 2004-01-03 Ranbaxy Lab Ltd
AR035728A1 (es) * 2001-01-16 2004-07-07 Merck & Co Inc Proceso perfeccionado para la sintesis de carbapenem
OA12608A (en) * 2001-05-18 2006-06-08 Ranbaxy Lab Ltd Process for the isolation of crystalline imiponem.
CA2457642C (en) * 2001-09-26 2009-01-06 Merck & Co., Inc. Crystalline forms of ertapenem sodium
EP1474426B8 (en) * 2001-09-26 2011-10-12 Merck Sharp & Dohme Corp. Process for making carbapenem compounds

Also Published As

Publication number Publication date
JP2005509037A (ja) 2005-04-07
EP1448563A1 (en) 2004-08-25
US7332600B2 (en) 2008-02-19
PL368984A1 (en) 2005-04-04
ZA200403961B (en) 2005-09-19
EA200400682A1 (ru) 2004-10-28
HRP20040552A2 (en) 2004-10-31
BR0214209A (pt) 2004-10-26
CN1608066A (zh) 2005-04-20
KR20050044506A (ko) 2005-05-12
WO2003042215A1 (en) 2003-05-22
CA2467427A1 (en) 2003-05-22
US20050004359A1 (en) 2005-01-06
MXPA04004604A (es) 2004-09-10
HUP0402112A2 (hu) 2005-02-28

Similar Documents

Publication Publication Date Title
AR037551A1 (es) Proceso para la preparacion de imipenem monohidratado cristalino y compuesto
WO2007143507A3 (en) Preparation and utility of substituted erythromycin analogs
PE20011050A1 (es) Compuestos antibioticos de azalida
CA2336809A1 (en) Water miscible macrolide solutions
WO2008039420A3 (en) Novel inhibitors of beta-lactamase
BRPI0410685B8 (pt) processos de purificação do 1,3-propanodiol e composição
HK1143809A1 (en) Beta-lactamase inhibitors
BR0016810A (pt) Processo para monitorar as populações microbiológicas planctÈnicas e sésseis em um sistema de água industrial
TNSN08407A1 (en) Organic compounds
CA2412541A1 (en) 9.alpha.-chloro-6.alpha.-fluoro-17.alpha.-hydroxy-16-methyl-17-.beta.-methoxycarbonyl-androst-1,4-dienes esterified in position 17.alpha. by a cyclic acyl group
EP2452935A3 (en) Tetracycline derivatives for the treatment of bacterial, viral and parasitic infections
MY156254A (en) Salts and polymorphs of a tetracycline compound
WO2008143343A1 (ja) １４位置換基に複素芳香環カルボン酸構造を有するムチリン誘導体
WO2012031298A3 (en) Ethynylbenzene derivatives
SE9402595L (sv) Förfarande för kristallisation av iopamidol
ES2103394T3 (es) Nuevos derivados de diclavulanato de alquilendiamonio, procedimientos para su preparacion y para su utilizacion.
WO2007142548A3 (en) Vesicular formulations containing organic acid prodrugs, process for their preparation
CA2133885A1 (en) Crystalline inclusion complex of diclofenac with beta-cyclodextrin
GB0012383D0 (en) Organic compounds
AR035553A1 (es) Formas cristalinas de melagatran, proceso para su produccion, formulacion farmaceutica, y uso de este compuesto en la elaboracion de medicamentos.
GR3025394T3 (en) Process for the purifying of waters for human consumption.
AR046229A1 (es) Procesos para la preparacion de cefalosporina 3-(2-vinilo sustituido) altamente pura
ECSP003680A (es) Proceso para derivados del acido fenilacetico
EP1078911A3 (de) Verfahren zum Feinreinigen einer wässrigen Lösung, die eine fermentativ hergestellte organische Säure enthält
AU3655400A (en) Utilization of porphyrin derivatives in aquaria

Legal Events

Date Code Title Description
FA Abandonment or withdrawal